golf ... just "guessing" because that is what we are typically forced to do, but it may not be material because it isn't settled or confirmed yet?

Getting to ANY form of registration/approval/commercialization/revenues for ANYTHING would be HUGE for RVX & apabetalone obviously. Pushing out timelines would be a bummer.

I would anticipate better abswers from Bear, Cityslickers, Barsax, etc ... but perhaps concurrent studies could be run, perhaps with the same patient base? A study for impact on Covid patients and the ACE2/cytokine storm, and a study for heart damage repair as patients continue forward in the study?? Or, perhaps multiple groups and data collection within a single study, perhaps with an ability to utilize the cytokine storm and ACE2 reduction benefits data from the study to accelerate that particular indication since enough data could/should be collected in shorter order than heart repair? ... yes, just guessing/speculating.

Hopefully, we will hear more on all of this directly from the horse's mouth?! ... hopefully soon (not holding my breath though).